These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 29929537

  • 1. Aggression Following Traumatic brain injury: Effectiveness of Risperidone (AFTER): study protocol for a feasibility randomised controlled trial.
    Deb S, Leeson V, Aimola L, Bodani M, Li L, Weaver T, Sharp D, Crawford M.
    Trials; 2018 Jun 21; 19(1):325. PubMed ID: 29929537
    [Abstract] [Full Text] [Related]

  • 2. Risperidone versus placebo for aggression following traumatic brain injury: a feasibility randomised controlled trial.
    Deb S, Aimola L, Leeson V, Bodani M, Li L, Weaver T, Sharp D, Bassett P, Crawford M.
    BMJ Open; 2020 Sep 10; 10(9):e036300. PubMed ID: 32912978
    [Abstract] [Full Text] [Related]

  • 3. Neuroleptics in the treatment of aggressive challenging behaviour for people with intellectual disabilities: a randomised controlled trial (NACHBID).
    Tyrer P, Oliver-Africano P, Romeo R, Knapp M, Dickens S, Bouras N, Ahmed Z, Cooray S, Deb S, Murphy D, Hare M, Meade M, Reece B, Kramo K, Bhaumik S, Harley D, Regan A, Thomas D, Rao B, Karatela S, Lenôtre L, Watson J, Soni A, Crawford M, Eliahoo J, North B.
    Health Technol Assess; 2009 Apr 10; 13(21):iii-iv, ix-xi, 1-54. PubMed ID: 19397849
    [Abstract] [Full Text] [Related]

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A pilot randomised controlled trial of community-led ANtipsychotic Drug REduction for Adults with Learning Disabilities.
    McNamara R, Randell E, Gillespie D, Wood F, Felce D, Romeo R, Angel L, Espinasse A, Hood K, Davies A, Meek A, Addison K, Jones G, Deslandes P, Allen D, Knapp M, Thapar A, Kerr M.
    Health Technol Assess; 2017 Aug 01; 21(47):1-92. PubMed ID: 28857740
    [Abstract] [Full Text] [Related]

  • 7. A group memory rehabilitation programme for people with traumatic brain injuries: the ReMemBrIn RCT.
    das Nair R, Bradshaw LE, Carpenter H, Clarke S, Day F, Drummond A, Fitzsimmons D, Harris S, Montgomery AA, Newby G, Sackley C, Lincoln NB.
    Health Technol Assess; 2019 Apr 01; 23(16):1-194. PubMed ID: 31032782
    [Abstract] [Full Text] [Related]

  • 8. Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial.
    Tyrer P, Oliver-Africano PC, Ahmed Z, Bouras N, Cooray S, Deb S, Murphy D, Hare M, Meade M, Reece B, Kramo K, Bhaumik S, Harley D, Regan A, Thomas D, Rao B, North B, Eliahoo J, Karatela S, Soni A, Crawford M.
    Lancet; 2008 Jan 05; 371(9606):57-63. PubMed ID: 18177776
    [Abstract] [Full Text] [Related]

  • 9. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH, Merry SN, Hetrick SE, Stasiak K.
    Cochrane Database Syst Rev; 2012 Sep 12; (9):CD008559. PubMed ID: 22972123
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT.
    Crawford MJ, Thana L, Evans R, Carne A, O'Connell L, Claringbold A, Saravanamuthu A, Case R, Munjiza J, Jayacodi S, Reilly JG, Hughes E, Hoare Z, Barrett B, Leeson VC, Paton C, Keown P, Pappa S, Green C, Barnes TR.
    Health Technol Assess; 2020 Sep 12; 24(44):1-54. PubMed ID: 32930090
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
    Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, Lee E, Lyons B, Grossman F.
    J Clin Psychiatry; 2003 Feb 12; 64(2):134-43. PubMed ID: 12633121
    [Abstract] [Full Text] [Related]

  • 15. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
    Christie D, Thompson R, Sawtell M, Allen E, Cairns J, Smith F, Jamieson E, Hargreaves K, Ingold A, Brooks L, Wiggins M, Oliver S, Jones R, Elbourne D, Santos A, Wong IC, O'Neill S, Strange V, Hindmarsh P, Annan F, Viner R.
    Health Technol Assess; 2014 Mar 12; 18(20):1-202. PubMed ID: 24690402
    [Abstract] [Full Text] [Related]

  • 16. Paliperidone palmitate for schizophrenia.
    Nussbaum AM, Stroup TS.
    Cochrane Database Syst Rev; 2012 Jun 13; (6):CD008296. PubMed ID: 22696377
    [Abstract] [Full Text] [Related]

  • 17. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.
    Health Technol Assess; 2006 May 13; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [Abstract] [Full Text] [Related]

  • 18. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
    McEniery CM, Fisk M, Miles K, Kaloyirou F, Hubsch A, Smith J, Wilkinson IB, Cheriyan J.
    Trials; 2020 Jul 02; 21(1):604. PubMed ID: 32616067
    [Abstract] [Full Text] [Related]

  • 19. Effects of transcranial direct current stimulation on patients with disorders of consciousness after traumatic brain injury: study protocol for a randomized, double-blind controlled trial.
    Li S, Dong X, Sun W, Zhao N, Yu G, Shuai L.
    Trials; 2019 Oct 17; 20(1):596. PubMed ID: 31623656
    [Abstract] [Full Text] [Related]

  • 20. High-dose oral vitamin D supplementation and mortality in people aged 65-84 years: the VIDAL cluster feasibility RCT of open versus double-blind individual randomisation.
    Rake C, Gilham C, Bukasa L, Ostler R, Newton M, Peto Wild J, Aigret B, Hill M, Gillie O, Nazareth I, Sasieni P, Martineau A, Peto J.
    Health Technol Assess; 2020 Feb 17; 24(10):1-54. PubMed ID: 32090730
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.